Axicabtagene Ciloleucel,Cyclophosphamide,Fludarabine
Gilead
['zuma-7', 'paradigm', 'thank you']
zuma-7 is the first trial in nearly 30 years to significantly improve overall survival for patients with relapsed/refractory large b-cell in 2l therapy. thank you to all the patients who participated in this paradigm shifting trial. #asco23 
Director of Clinical Research, Section Chief Aggressive Lymphoma @MDAndersonNews, @ASCO Assoc Board Treasurer & Govt Relations Committee Chair, Opinions mine